Interleukin-6 in myeloma/plasmacytoma.
Suematsu
S
S
Division of Immunology, Osaka University, Japan.
Matsusaka
T
T
Matsuda
T
T
Hirano
T
T
Kishimoto
T
T
D000818:Animals; D004742:Enhancer Elements, Genetic; D005803:Genes, Immunoglobulin; D005813:Genes, Synthetic; D016259:Genes, myc; D020022:Genetic Predisposition to Disease; D006183:H-2 Antigens / Q000235:genetics; D064532:Histocompatibility Antigen H-2D; D006801:Humans; D007148:Immunoglobulin mu-Chains / Q000235:genetics; D015850:Interleukin-6 / Q000235:genetics / Q000502:physiology*; D008221:Lymphoid Tissue / Q000473:pathology; D008232:Lymphoproliferative Disorders / Q000209:etiology*; D051379:Mice; D008807:Mice, Inbred BALB C / Q000235:genetics*; D008810:Mice, Inbred C57BL / Q000235:genetics; D008814:Mice, Inbred NZB; D008819:Mice, Nude; D008822:Mice, Transgenic / Q000235:genetics; D010950:Plasma Cells / Q000473:pathology*; D010954:Plasmacytoma / Q000209:etiology* / Q000235:genetics; D011401:Promoter Regions, Genetic; D011993:Recombinant Fusion Proteins / Q000235:genetics / Q000633:toxicity
D006183:H-2 Antigens; D064532:Histocompatibility Antigen H-2D; D007148:Immunoglobulin mu-Chains; D015850:Interleukin-6; D011993:Recombinant Fusion Proteins